Latest news

Arrowhead wins first FDA approval, igniting biotech rivalry with Ionis

Arrowhead wins first FDA approval, igniting biotech rivalry with Ionis

Eduardo Longoria
Daily Snap - 19. November 2025

Daily Snap - 19. November 2025

Joachim Eeckhout
Roche’s breast cancer pill hits key goal and becomes leader in the oral SERD race

Roche’s breast cancer pill hits key goal and becomes leader in the oral SERD race

Eduardo Longoria
Zymeworks pivots to royalty-first model after cancer drug success

Zymeworks pivots to royalty-first model after cancer drug success

Eduardo Longoria
Daily Snap - 18. November 2025

Daily Snap - 18. November 2025

Joachim Eeckhout
J&J grabs a hold of Halda for $3B to gain the novel “hold and kill” cancer tech

J&J grabs a hold of Halda for $3B to gain the novel “hold and kill” cancer tech

Eduardo Longoria
Solve Therapeutics secures $120M to advance smarter cancer-targeting drugs

Solve Therapeutics secures $120M to advance smarter cancer-targeting drugs

Eduardo Longoria
Daily Snap - 17. November 2025

Daily Snap - 17. November 2025

Joachim Eeckhout
Lundbeck’s surprise bid throws Alkermes’ $2.1B deal for Avadel into doubt

Lundbeck’s surprise bid throws Alkermes’ $2.1B deal for Avadel into doubt

Eduardo Longoria
Merck catches a long-acting flu drug for $9.2B to replace vaccines

Merck catches a long-acting flu drug for $9.2B to replace vaccines

Eduardo Longoria
Daily Snap - 14. November 2025

Daily Snap - 14. November 2025

Joachim Eeckhout
Novartis discovers a new path to fight malaria’s drug resistance

Novartis discovers a new path to fight malaria’s drug resistance

Eduardo Longoria
FirstBack
23456789
Next Last